BrightInsight launches digital health platform

Digital pharmaceutical and medical technology company BrightInsight launched its connected diagnostics platform at the 2022 American Association for Clinical Chemistry Annual Scientific Meeting and Lab Clinic Expo.

Advertisement

The connected diagnostics platform includes four different tools into one platform used for in vitro diagnostics. Analytics dashboards, integration middleware, workflow portals and a proxy agent are all included in the connected digital platform, according to a July 25 news release.

“The BrightInsight connected diagnostics platform is a one-stop solution for in vitro diagnostics manufacturers to maximize workflow and visibility, manage devices more efficiently and reduce costs,” said Kal Patel, MD, CEO and co-founder of BrightInsight. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.